All In MedTech

FDA Clearance Tracker · P150017-S007

Cartiva SCI reusable instrumentation

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 28, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 28, 2018

Approved

Time to decision

286 days

Received Nov 15, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P150017-S007
Device name
Cartiva SCI reusable instrumentation
Applicant
Cartiva, Inc.
Applicant location
Alpharetta, GA
Received
Nov 15, 2017
Decided
Aug 28, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P150017

Device type

Device class
Class III

Every decision under product code PNW

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Arcamed LLC, 5101 Decatur Blvd Ste A, Indianapolis, Indiana to manufacture the instruments for Cartiva Synthetic Cartilage Implant.

Source documents

Other decisions for Cartiva, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.